Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

North America and Europe Dermal Fillers Market — Insights

Dermal fillers, also known as injectable fillers or soft tissue fillers, are categorized as medical devices by the U.S. FDA. Dermal fillers are used to reduce wrinkles and smoothen skin appearance caused by ageing, acne or scars. The application areas are face including Nasolabial fold, cheeks, lips, corners of the eye, and dorsal area of hands. 

Statistics:

North America and Europe dermal fillers market is estimated to account for US$ 2981.1 Mn in terms of value by the end of 2027.

North America and Europe Dermal Fillers Market: Drivers

Increasing geriatric population is expected to propel growth of North America and Europe dermal fillers market over the forecast period. For instance, according to the U.S. Census Bureau, geriatric population in the U.S. is expected to reach 77 million by 2035.

Moreover, increasing healthcare expenditure is also expected to aid in growth of the market. For instance, according to the Centers for Medicare & Medicaid Services (CMS), health spending in the U.S. is projected to grow at an average rate of 5.5% per year for 2018-27 and to reach nearly US$ 6.0 trillion by 2027.

North America region held dominant position in North America and Europe dermal fillers market in 2019, accounting for 59.6% share in terms of value, followed by 2027.

Figure 1. North America and Europe Dermal Fillers Market Share (%), by Region, 2019

North America & Europe Dermal Filler  | Coherent Market Insights

North America and Europe Dermal Fillers Market: Restraints

High cost of physician services for procedures and the need for multiple sessions for desired results is expected to hinder growth of North America and Europe dermal fillers market. The service cost of physicians or surgeons is around 40 to 50% of the dermal filler cost. The fillers like HA, PLLA, CaHA and collagen are biodegradable and last for 3 to 24 months. Most of them are naturally present in body and therefore get degraded quickly. This in turn requires multiple sessions for attaining the desired results, which further increases the overall cost of the procedure. 

Majority of the dermal fillers currently available are absorbable / bio degradable except for PMMA fillers. Biodegradable fillers last for 3 to 24 months, whereas PMMA fillers last for 4-5 years. This makes the procedure repetitive after the certain time, which may lead to a shift towards surgical facial rejuvenation instead of dermal fillers, which limits growth of the market.

North America and Europe Dermal Fillers Market: Opportunities 

Players in the market may focus on offering inexpensive, safe, painless to inject, hypoallergenic, and long lasting dermal fillers. Moreover, the product should offer reliable and expected results, be ready-to-use, and the time required to inject the filler should be less.

R&D in dermal fillers is also expected aid in growth of the market. For instance, according to a new study, ‘An Objective, Quantitative, Dynamic Assessment of Hyaluronic Acid Fillers That Adapt to Facial Movement’, published in the February 2020 issue of Plastic and Reconstructive Surgery, dermal fillers also restore a more youthful pattern of facial movement and expressiveness apart from filling wrinkles.

North America & Europe Dermal Filler  | Coherent Market Insights

Absorbable segment in North America and Europe dermal fillers market was valued at US$ 1,723.7 Mn in 2019 and is expected to reach US$ 2,936.9 Mn by 2027 at a CAGR of 6.9% during the forecast period.

Market Trends/Key Takeaways

The market is witnessing high adoption of injectable dermal fillers as a minimally invasive approach to reduce facial lines and wrinkles. For instance, according to American Society of Plastic Surgeons (ASPS), around 2.7 million dermal filler injection procedures were performed in 2018 in the U.S.

Dermal fillers are also used in enhancement of dorsal area of hands and for HIV-induced facial lipoatrophy. CaHA fillers are used for the treatment of paralyzed vocal cords and dentists also can perform dermal filler procedure for facial rejuvenation to improve post dental procedures facial aesthetics.

Hand rejuvenation is gaining preference among the populace. However, there are few treatments approved for the correction of volume loss in the hand, which include application of PLA and CaHA.

Regulations

U.S.

  • The FDA authorizes the use of dermal fillers for skin smoothening and enhancement, wrinkle reduction, HIV-induced lipoatrophy, and for the treatment of paralyzed vocal cords.
  • A manufacturer must obtain a premarket approval (PMA) before commercializing the device
  • FDA mandated on post approval studies and recommended labeling for dermal fillers
  • Dermal filler manufacturers were conditioned during PMA to submit Post Approval Studies to understand and evaluate the post application effects of the dermal fillers. These devices require a PMA application before marketing and commercialization. Also, the labeling is mandatory as per the FDA norms with dermal fillers.

Value Chain Analysis –

Segmentation

North America & Europe Dermal Filler  | Coherent Market Insights

North America & Europe Dermal Filler  | Coherent Market Insights

North America and Europe Dermal Fillers Market: Competitive Landscape 

Major players operating in North America and Europe dermal fillers market include, Galderma Pharma S.A., Sinclair Pharma plc., Allergan Plc., Anika Therapeutics Inc., Merz Pharma GmbH & Co. KGaA, Suneva Medical Inc., Teoxane Laboratories Inc., Prollenium Medical Technologies Inc., Adoderm GmbH, and Laboratoires Vivacy SAS.

North America and Europe Dermal Fillers Market: Key Developments

Major players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio. For instance, in January 2020, Revance Therapeutics, Inc. signed an agreement with TEOXANE SA for distribution of TEOXANE SA’s Resilient Hyaluronic Acid technology in the U.S.

In January 2020, Histogen, Inc., a regenerative medicine company, expanded its partnership with Allergan, Inc., under which Allergan acquired exclusive rights to incorporate and commercialize Histogen's cell conditioned media in microdermabrasion therapies and exclusive rights to new Histogen intellectual property in the aesthetic field.

Dermal fillers, also known as injectable fillers or soft tissue fillers used to reduce wrinkles and smoothen skin appearance caused by ageing, acne or scars. Dermal fillers are injected with small gauge injectors into deep dermal area to fill the space and also to induce the body production of collagen. Derma fillers are composed of Hyaluronic acid (HA), calcium hydroxyapatite (CaHA), poly-lactic acid (PLLA), collagen, and polymethylmethacrylate (non-absorbable). Increasing demand for non-invasive aesthetic procedures is expected to boost growth of North America and Europe dermal fillers market over the forecast period. Furthermore, increasing adoption of derma fillers in HIV induced facial lipoatrophy, and application of CaHA fillers for treatment of paralyzed vocal cords is anticipated to propel the growth of the market during the forecasted period.

Key features of the study:

  • This report provides in-depth analysis of the North America and Europe Dermal Fillers market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the North America and Europe Dermal Fillers market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Galderma Pharma S.A., Sinclair Pharma plc. , Allergan Plc., Anika Therapeutics Inc., Merz Pharma GmbH & Co. KGaA, Suneva Medical Inc., Teoxane Laboratories Inc., Prollenium Medical Technologies Inc., Adoderm GmbH, and Laboratoires Vivacy SAS.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The North America and Europe Dermal Fillers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America and Europe Dermal Fillers market

Detailed Segmentation:

  • North America and Europe Dermal Fillers Market, By Product Type:
    • Absorbable
    • Non-absorbable
  • North America and Europe Dermal Fillers Market, By Ingredients:
    • Hyaluronic acid
    • Poly-L-Lactic acid
    • Calcium Hydroxylapatite
    • Polymethylmethacrylate
    • Collagen
  • North America and Europe Dermal Fillers Market, By Distribution Channel:
    • Retail pharmacies and drug stores
    • Clinics and Hospital pharmacies
    • Online sales
  • North America and Europe Dermal Fillers Market, By Region:
    • North America
      • By Product Type
        • Absorbable
        • Non-absorbable
      • By Ingredients
        • Hyaluronic acid
        • Poly-L-Lactic acid
        • Calcium Hydroxylapatite
        • Polymethylmethacrylate
        • Collagen
      • By Distribution Channel
        • Retail pharmacies and drug stores
        • Clinics and Hospital pharmacies
        • Online sales
      • By Country
        • U.S.
        • Canada
    • Western Europe
      • By Product Type
        • Absorbable
        • Non-absorbable
      • By Ingredients
        • Hyaluronic acid
        • Poly-L-Lactic acid
        • Calcium Hydroxylapatite
        • Polymethylmethacrylate
        • Collagen
      • By Distribution Channel
        • Retail pharmacies and drug stores
        • Clinics and Hospital pharmacies
        • Online sales
      • By Country
        • UK
        • Germany
        • France
        • Rest of Western Europe
    • Eastern Europe
      • By Product Type
        • Absorbable
        • Non-absorbable
      • By Ingredients
        • Hyaluronic acid
        • Poly-L-Lactic acid
        • Calcium Hydroxylapatite
        • Polymethylmethacrylate
        • Collagen
      • By Distribution Channel
        • Retail pharmacies and drug stores
        • Clinics and Hospital pharmacies
        • Online sales
      • By Country
        • Russia
        • Poland
        • Rest of Eastern Europe
  • Company Profiles
    • Galderma Pharma S.A.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Sinclair Pharma plc.
    • Allergan Plc.
    • Anika Therapeutics Inc.
    • Merz Pharma GmbH & Co. KGaA
    • Suneva Medical Inc.
    • Teoxane Laboratories Inc.
    • Prollenium Medical Technologies Inc.
    • Adoderm GmbH
    • Laboratoires Vivacy SAS

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Ingredients
      • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
        • Restraints
        • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Reimbursement Scenario
    • Merger and Acquisition Scenario
    • PEST Analysis
  4. North America and Europe Dermal Fillers Market, By Product Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Absorbable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Non-absorbable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. North America and Europe Dermal Fillers Market, By Ingredients, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hyaluronic acid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Poly-L-Lactic acid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Calcium Hydroxylapatite
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Polymethylmethacrylate
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Collagen
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. North America and Europe Dermal Fillers Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Retail pharmacies and drug stores
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Clinics and Hospital pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Online sales
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. North America and Europe Dermal Fillers Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Ingredients, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.S.
        • Canada
    • Western Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Ingredients, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • UK
        • Germany
        • France
        • Rest of Western Europe
    • Eastern Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Ingredients, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • Russia
        • Poland
        • Rest of Eastern Europe
  8. Competitive Landscape
    • Company Profiles
      • Galderma Pharma S.A.*
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sinclair Pharma plc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Allergan Plc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Anika Therapeutics Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merz Pharma GmbH & Co. KGaA
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Suneva Medical Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Teoxane Laboratories Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Prollenium Medical Technologies Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Adoderm GmbH
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Laboratoires Vivacy SAS
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 20 market data tables and 16 figures on "Dermal Fillers Market” – North America and Europe forecast to 2027.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner